DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

32.30 -0.02 (-0.06%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SGEN $32.30 -0.06%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $32.22
Previous Close $32.32
Daily Range $31.99 - $32.64
52-Week Range $30.05 - $55.99
Market Cap $4.0B
P/E Ratio -62.15
Dividend (Yield) $0.00 (0.0%)
Volume 719,709
Average Daily Volume 1,494,977
Current FY EPS -$0.66

Sector

Healthcare

Industry

Drugs

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seattlegenetics.com/

News & Commentary

Why Seattle Genetics, Inc. Stock Dove 12% in December

Seattle Genetics' shares get hammered following impressive clinical data from its rivals at the American Society of Hematology's annual meeting. Find out whether this dip represents a buying opportunity or a red flag.

First Week of SGEN September 18th Options Trading

Commit To Buy Seattle Genetics At $25, Earn 8.5% Annualized Using Options

ALPS Puts Twist On Biotech Investing With Medical Breakthrough ETF

Eli Lilly Inks Oncology Deals with Merck, Bristol-Myers - Analyst Blog

Seattle Genetics, Bristol-Myers to Study Adcetris-Opdivo - Analyst Blog

New Biotech ETF From ALPS

Bull of the Day: Incyte (INCY) - Bull of the Day

Seattle Genetics And Agios Pharmaceuticals: Opportunity Or Danger?

Despite Huge Rally, High-Profile Insiders Still Buying Stocks

See More SGEN News...

SGEN's Top Competitors

SGEN $32.30 (-0.06%)
Current stock: SGEN
AMGN $159.81 (0.15%)
Current stock: AMGN
GILD $105.54 (0.38%)
Current stock: GILD
BIIB $357.63 (1.13%)
Current stock: BIIB